220 related articles for article (PubMed ID: 23082147)
1. The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.
Chen Z; Ding W; Xu K; Tan J; Sun C; Gou Y; Tong S; Xia G; Fang Z; Ding Q
PLoS One; 2012; 7(10):e47199. PubMed ID: 23082147
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system.
Nishiyama N; Kitamura H; Maeda T; Takahashi S; Masumori N; Hasegawa T; Tsukamoto T
Jpn J Clin Oncol; 2013 Nov; 43(11):1124-31. PubMed ID: 23980236
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
Soukup V; Čapoun O; Cohen D; Hernández V; Babjuk M; Burger M; Compérat E; Gontero P; Lam T; MacLennan S; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Yuan Y; Zigeuner R
Eur Urol; 2017 Nov; 72(5):801-813. PubMed ID: 28457661
[TBL] [Abstract][Full Text] [Related]
5. Bladder papillary urothelial neoplasm of low malignant potential in Chinese: a clinical and pathological analysis.
Zhang XK; Wang YY; Chen JW; Qin T
Int J Clin Exp Pathol; 2015; 8(5):5549-55. PubMed ID: 26191263
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?
Gontero P; Gillo A; Fiorito C; Oderda M; Pacchioni D; Casetta G; Peraldo F; Zitella A; Tizzani A; Ricceri F
Urol Int; 2014; 92(2):136-42. PubMed ID: 24080613
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUC1 (Ma695) in noninvasive papillary urothelial neoplasm according to the 2004 World Health Organization classification of the noninvasive urothelial neoplasm. An immunologic tool for the pathologist?
Garbar C; Mascaux C
Anal Quant Cytol Histol; 2011 Oct; 33(5):277-82. PubMed ID: 22611755
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
van Rhijn BWG; Hentschel AE; Bründl J; Compérat EM; Hernández V; Čapoun O; Bruins HM; Cohen D; Rouprêt M; Shariat SF; Mostafid AH; Zigeuner R; Dominguez-Escrig JL; Burger M; Soukup V; Gontero P; Palou J; van der Kwast TH; Babjuk M; Sylvester RJ;
Eur Urol Oncol; 2021 Apr; 4(2):182-191. PubMed ID: 33423944
[TBL] [Abstract][Full Text] [Related]
11. Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.
van Rhijn BW; Musquera M; Liu L; Vis AN; Zuiverloon TC; van Leenders GJ; Kirkels WJ; Zwarthoff EC; Boevé ER; Jöbsis AC; Bapat B; Jewett MA; Zlotta AR; van der Kwast TH
Mod Pathol; 2015 May; 28(5):695-705. PubMed ID: 25431236
[TBL] [Abstract][Full Text] [Related]
12. Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up.
Mariappan P; Fineron P; O'Donnell M; Gailer RM; Watson DJ; Smith G; Grigor KM
World J Urol; 2021 Feb; 39(2):425-431. PubMed ID: 32266509
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological study of the 1973 who classification and the WHO/ISUP classification in pTa bladder carcinoma].
Ishida R; Tsuzuki T; Yoshida S; Shiota T; Nisikimi T; Yamada H; Yokoi K; Kobayashi H
Nihon Hinyokika Gakkai Zasshi; 2010 May; 101(4):609-14. PubMed ID: 20535989
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.
Maxwell JP; Wang C; Wiebe N; Yilmaz A; Trpkov K
Diagn Pathol; 2015 Mar; 10():3. PubMed ID: 25886613
[TBL] [Abstract][Full Text] [Related]
15. Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC).
Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
J Cancer; 2017; 8(15):2885-2891. PubMed ID: 28928878
[No Abstract] [Full Text] [Related]
16. Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer.
Passoni N; Gayed B; Kapur P; Sagalowsky AI; Shariat SF; Lotan Y
Urol Oncol; 2016 Nov; 34(11):485.e7-485.e14. PubMed ID: 27637323
[TBL] [Abstract][Full Text] [Related]
17. Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors.
Pellucchi F; Freschi M; Ibrahim B; Rocchini L; Maccagnano C; Briganti A; Rigatti P; Montorsi F; Colombo R
J Urol; 2011 Dec; 186(6):2194-9. PubMed ID: 22019037
[TBL] [Abstract][Full Text] [Related]
18. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
[TBL] [Abstract][Full Text] [Related]
19. Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer.
Fujii N; Hoshii Y; Hirata H; Mori J; Shimizu K; Kobayashi K; Kawai Y; Inoue R; Yamamoto Y; Matsumoto H; Nagao K; Matsuyama H
Jpn J Clin Oncol; 2017 Jun; 47(6):560-567. PubMed ID: 28334788
[TBL] [Abstract][Full Text] [Related]
20. Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?
Pellucchi F; Freschi M; Moschini M; Rocchini L; Maccagnano C; Nazareno S; Bergamaschi F; Montorsi F; Colombo R
BJU Int; 2015 Feb; 115(2):267-73. PubMed ID: 25756136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
